Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

GHRP-2 and Tesamorelin Interaction: Synergistic | Peptide Database

Can you take GHRP-2 with Tesamorelin? Synergistic interaction (55% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

GHRP-2

Growth Hormone Releasing Peptide-2 | Pralmorelin

GHRP-2 acts as a synthetic agonist of ghrelin, binding to the growth hormone secretagogue receptor (GHS-R1a) in the hypothalamus and pituitary. This stimulates cAMP production and promotes pulsatile release of endogenous growth hormone without suppressing natural feedback loops.

Tesamorelin

GHRH Analog | Visceral Fat Reduction

Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take GHRP-2 with Tesamorelin?

Yes, GHRP-2 and Tesamorelin can generally be taken together. GHRP-2 and Tesamorelin amplify GH release through complementary mechanisms (GHRH primes, GHRP triggers). This is a well-established synergistic combination — expect significantly greater GH output than either alone.

Is GHRP-2 and Tesamorelin safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between GHRP-2 and Tesamorelin?

GHRP-2 and Tesamorelin amplify GH release through complementary mechanisms (GHRH primes, GHRP triggers). This is a well-established synergistic combination — expect significantly greater GH output than either alone. This assessment has 55% confidence and is inferred from pharmacological mechanism analysis.

How should I time GHRP-2 and Tesamorelin?

GHRP-2 has a half-life of ~30 minutes and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question